Skip to main content

. 1964 Sep;23(5):397–404. doi: 10.1136/ard.23.5.397

Ibufenac in the Treatment of Arthritis

M Thompson ¹, P Stephenson ¹, J S Percy ^1,^*

PMCID: PMC1010380 PMID: 14206219

397

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ADAMS S. S., CLIFFE E. E., LESSEL B., NICHOLSON J. S. SOME BIOLOGICAL PROPERTIES OF 'IBUFENAC', A NEW ANTI-RHEUMATIC DRUG. Nature. 1963 Oct 19;200:271–272. doi: 10.1038/200271b0. [DOI] [PubMed] [Google Scholar]
CHALMERS T. M. CLINICAL TRIALS OF A NEW DRUG, IBUFENAC, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A PRELIMINARY REPORT. Ann Rheum Dis. 1963 Sep;22:358–362. doi: 10.1136/ard.22.5.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
DRIVSHOLM A., MADSEN S. The influence of treatment with sodium salicylate on the serum glutamic oxalacetic transaminase activity. Scand J Clin Lab Invest. 1961;13:442–446. [PubMed] [Google Scholar]
HAJNAL J., SHARP J., POPERT A. J. A method for testing analgesics in rheumatoid arthritis using a sequential procedure. Ann Rheum Dis. 1959 Sep;18:189–206. doi: 10.1136/ard.18.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
TUDHOPE G. R. FAECAL BLOOD LOSS DURING TREATMENT WITH IBUFENAC, A NEW ANALGESIC DRUG. Ann Rheum Dis. 1964 Jan;23:30–32. doi: 10.1136/ard.23.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES